 | • レポートコード：QYR9ST03755 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥828,800 (USD5,600) | ▷ お問い合わせ |
| Enterprise License | ￥1,657,600 (USD11,200) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の抗リウマチ薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。抗リウマチ薬の種類別には、非ステロイド系抗炎症薬、ステロイド系抗炎症薬、遅効性薬物、免疫学的準備に、用途別には、製薬産業、病院及びクリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・抗リウマチ薬の種類別市場規模：非ステロイド系抗炎症薬、ステロイド系抗炎症薬、遅効性薬物、免疫学的準備 ・抗リウマチ薬の用途別市場規模：製薬産業、病院及びクリニック、その他 ・抗リウマチ薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：AbbVie、Amgen、Pfizer、Roche Holding AG、Novartis International AG、Johnson & Johnson、Bristol-Myers Squibb、Merck、UCB S.A.、Eli Lilly and Company ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Antirheumatics Pharmaceutical refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.The Antirheumatics Pharmaceutical market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antirheumatics Pharmaceutical.
This study focuses on the production side and consumption side of Antirheumatics Pharmaceutical, presents the global Antirheumatics Pharmaceutical market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
In terms of production side, this report researches the Antirheumatics Pharmaceutical capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Antirheumatics Pharmaceutical by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.
This report includes the following manufacturers; we can also add the other companies as you want.
AbbVie
Amgen
Pfizer
Roche Holding AG
Novartis International AG
Johnson & Johnson
Bristol-Myers Squibb
Merck
UCB S.A.
Eli Lilly and Company
Market Segment by Product Type
Non-Steroidal Anti-Inflammatory Drugs
Steroidal Anti-Inflammatory Drugs
Slow Acting Drug
Immunological Preparation
Market Segment by Application
Pharmaceutical Industry
Hospital and Clinic
Other
Key Regions split in this report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Antirheumatics Pharmaceutical status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Antirheumatics Pharmaceutical manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antirheumatics Pharmaceutical are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type
1.3.2 Non-Steroidal Anti-Inflammatory Drugs
1.3.3 Steroidal Anti-Inflammatory Drugs
1.3.4 Slow Acting Drug
1.3.5 Immunological Preparation
1.4 Market Segment by Application
1.4.1 Global Antirheumatics Pharmaceutical Market Share by Application (2019-2025)
1.4.2 Pharmaceutical Industry
1.4.3 Hospital and Clinic
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Antirheumatics Pharmaceutical Production Value 2014-2025
2.1.2 Global Antirheumatics Pharmaceutical Production 2014-2025
2.1.3 Global Antirheumatics Pharmaceutical Capacity 2014-2025
2.1.4 Global Antirheumatics Pharmaceutical Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Antirheumatics Pharmaceutical Market Size CAGR of Key Regions
2.2.2 Global Antirheumatics Pharmaceutical Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Antirheumatics Pharmaceutical Capacity by Manufacturers
3.1.2 Global Antirheumatics Pharmaceutical Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Antirheumatics Pharmaceutical Revenue by Manufacturers (2014-2019)
3.2.2 Antirheumatics Pharmaceutical Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Antirheumatics Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.3 Antirheumatics Pharmaceutical Price by Manufacturers
3.4 Key Manufacturers Antirheumatics Pharmaceutical Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antirheumatics Pharmaceutical Market
3.6 Key Manufacturers Antirheumatics Pharmaceutical Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Non-Steroidal Anti-Inflammatory Drugs Production and Production Value (2014-2019)
4.1.2 Steroidal Anti-Inflammatory Drugs Production and Production Value (2014-2019)
4.1.3 Slow Acting Drug Production and Production Value (2014-2019)
4.1.4 Immunological Preparation Production and Production Value (2014-2019)
4.2 Global Antirheumatics Pharmaceutical Production Market Share by Type
4.3 Global Antirheumatics Pharmaceutical Production Value Market Share by Type
4.4 Antirheumatics Pharmaceutical Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antirheumatics Pharmaceutical Consumption by Application
6 Production by Regions
6.1 Global Antirheumatics Pharmaceutical Production (History Data) by Regions 2014-2019
6.2 Global Antirheumatics Pharmaceutical Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Antirheumatics Pharmaceutical Production Growth Rate 2014-2019
6.3.2 United States Antirheumatics Pharmaceutical Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Antirheumatics Pharmaceutical Import & Export
6.4 Europe
6.4.1 Europe Antirheumatics Pharmaceutical Production Growth Rate 2014-2019
6.4.2 Europe Antirheumatics Pharmaceutical Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Antirheumatics Pharmaceutical Import & Export
6.5 China
6.5.1 China Antirheumatics Pharmaceutical Production Growth Rate 2014-2019
6.5.2 China Antirheumatics Pharmaceutical Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Antirheumatics Pharmaceutical Import & Export
6.6 Japan
6.6.1 Japan Antirheumatics Pharmaceutical Production Growth Rate 2014-2019
6.6.2 Japan Antirheumatics Pharmaceutical Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Antirheumatics Pharmaceutical Import & Export
6.7 Other Regions
6.7.1 South Korea
6.7.2 India
6.7.3 Southeast Asia
7 Antirheumatics Pharmaceutical Consumption by Regions
7.1 Global Antirheumatics Pharmaceutical Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Antirheumatics Pharmaceutical Consumption by Type
7.2.2 North America Antirheumatics Pharmaceutical Consumption by Application
7.2.3 North America Antirheumatics Pharmaceutical Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Antirheumatics Pharmaceutical Consumption by Type
7.3.2 Europe Antirheumatics Pharmaceutical Consumption by Application
7.3.3 Europe Antirheumatics Pharmaceutical Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Antirheumatics Pharmaceutical Consumption by Type
7.4.2 Asia Pacific Antirheumatics Pharmaceutical Consumption by Application
7.4.3 Asia Pacific Antirheumatics Pharmaceutical Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Antirheumatics Pharmaceutical Consumption by Type
7.5.2 Central & South America Antirheumatics Pharmaceutical Consumption by Application
7.5.3 Central & South America Antirheumatics Pharmaceutical Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Antirheumatics Pharmaceutical Consumption by Type
7.6.2 Middle East and Africa Antirheumatics Pharmaceutical Consumption by Application
7.6.3 Central & South America Antirheumatics Pharmaceutical Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa
8 Company Profiles
8.1 AbbVie
8.1.1 AbbVie Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Antirheumatics Pharmaceutical
8.1.4 Antirheumatics Pharmaceutical Product Introduction
8.1.5 AbbVie Recent Development
8.2 Amgen
8.2.1 Amgen Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Antirheumatics Pharmaceutical
8.2.4 Antirheumatics Pharmaceutical Product Introduction
8.2.5 Amgen Recent Development
8.3 Pfizer
8.3.1 Pfizer Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Antirheumatics Pharmaceutical
8.3.4 Antirheumatics Pharmaceutical Product Introduction
8.3.5 Pfizer Recent Development
8.4 Roche Holding AG
8.4.1 Roche Holding AG Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Antirheumatics Pharmaceutical
8.4.4 Antirheumatics Pharmaceutical Product Introduction
8.4.5 Roche Holding AG Recent Development
8.5 Novartis International AG
8.5.1 Novartis International AG Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Antirheumatics Pharmaceutical
8.5.4 Antirheumatics Pharmaceutical Product Introduction
8.5.5 Novartis International AG Recent Development
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Antirheumatics Pharmaceutical
8.6.4 Antirheumatics Pharmaceutical Product Introduction
8.6.5 Johnson & Johnson Recent Development
8.7 Bristol-Myers Squibb
8.7.1 Bristol-Myers Squibb Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Antirheumatics Pharmaceutical
8.7.4 Antirheumatics Pharmaceutical Product Introduction
8.7.5 Bristol-Myers Squibb Recent Development
8.8 Merck
8.8.1 Merck Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Antirheumatics Pharmaceutical
8.8.4 Antirheumatics Pharmaceutical Product Introduction
8.8.5 Merck Recent Development
8.9 UCB S.A.
8.9.1 UCB S.A. Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Antirheumatics Pharmaceutical
8.9.4 Antirheumatics Pharmaceutical Product Introduction
8.9.5 UCB S.A. Recent Development
8.10 Eli Lilly and Company
8.10.1 Eli Lilly and Company Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Antirheumatics Pharmaceutical
8.10.4 Antirheumatics Pharmaceutical Product Introduction
8.10.5 Eli Lilly and Company Recent Development
9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Antirheumatics Pharmaceutical Capacity, Production Forecast 2019-2025
9.1.2 Global Antirheumatics Pharmaceutical Production Value Forecast 2019-2025
9.2 Antirheumatics Pharmaceutical Production and Production Value Forecast by Regions
9.2.1 Global Antirheumatics Pharmaceutical Production Value Forecast by Regions
9.2.2 Global Antirheumatics Pharmaceutical Production Forecast by Regions
9.3 Antirheumatics Pharmaceutical Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.3.5 Other Regions
9.4 Forecast by Type
9.4.1 Global Antirheumatics Pharmaceutical Production Forecast by Type
9.4.2 Global Antirheumatics Pharmaceutical Production Value Forecast by Type
10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Antirheumatics Pharmaceutical Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Antirheumatics Pharmaceutical Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Antirheumatics Pharmaceutical Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Antirheumatics Pharmaceutical Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Antirheumatics Pharmaceutical Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Antirheumatics Pharmaceutical Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antirheumatics Pharmaceutical Sales Channels
11.2.2 Antirheumatics Pharmaceutical Distributors
11.3 Antirheumatics Pharmaceutical Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Figure Antirheumatics Pharmaceutical Product Picture
Table Antirheumatics Pharmaceutical Key Market Segments
Table Major Manufacturers Antirheumatics Pharmaceutical Covered in This Report
Table Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type 2019-2025 (MT) & (Million US$)
Figure Global Antirheumatics Pharmaceutical Sales Market Shar by Type 2014-2025
Figure Non-Steroidal Anti-Inflammatory Drugs Figures
Table Major Manufacturers of Non-Steroidal Anti-Inflammatory Drugs
Figure Steroidal Anti-Inflammatory Drugs Figures
Table Major Manufacturers of Steroidal Anti-Inflammatory Drugs
Figure Slow Acting Drug Figures
Table Major Manufacturers of Slow Acting Drug
Figure Immunological Preparation Figures
Table Major Manufacturers of Immunological Preparation
Table Global Antirheumatics Pharmaceutical Market Share by Application 2019-2025 (MT)
Figure Pharmaceutical Industry Use Case
Figure Hospital and Clinic Use Case
Figure Other Use Case
Figure Antirheumatics Pharmaceutical Report Years Considered
Figure Global Antirheumatics Pharmaceutical Production Value Growth Rate 2014-2025 (Million US$)
Figure Global Antirheumatics Pharmaceutical Production 2014-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Capacity 2014-2025 (MT)
Table Key Manufacturers Antirheumatics Pharmaceutical Capacity (MT)
Figure Global Antirheumatics Pharmaceutical Price 2014-2025 (USD/MT)
Table Global Antirheumatics Pharmaceutical Market Size of Key Regions (Million USD) & (MT)
Table Global Antirheumatics Pharmaceutical Growth Rate of Key Regions 2019-2025 (Million USD)
Table Global Antirheumatics Pharmaceutical Market Share for of Regions 2019-2025 (MT)
Table Market Top Trends
Table Global Antirheumatics Pharmaceutical Capacity by Manufacturers (2014-2019) (MT)
Table Global Antirheumatics Pharmaceutical Capacity Market Share by Manufacturers (2014-2019)
Table Global Antirheumatics Pharmaceutical Production by Manufacturers (2014-2019) (MT)
Table Global Antirheumatics Pharmaceutical Production Share by Manufacturers (2014-2019)
Figure Global Antirheumatics Pharmaceutical Production Share by Manufacturers in 2018
Table Antirheumatics Pharmaceutical Revenue by Manufacturers (2014-2019) (Million USD)
Table Antirheumatics Pharmaceutical Revenue Share by Manufacturers (2014-2019)
Figure Antirheumatics Pharmaceutical Value Share by Manufacturers in 2018
Table Global Antirheumatics Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antirheumatics Pharmaceutical Price by Manufacturers 2014-2019 (USD/MT)
Table Key Manufacturers Antirheumatics Pharmaceutical Plants/Factories Distribution
Table Key Manufacturers Antirheumatics Pharmaceutical Area Served
Table Date of Key Manufacturers Enter into Antirheumatics Pharmaceutical Market
Table Key Manufacturers Antirheumatics Pharmaceutical Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-Steroidal Anti-Inflammatory Drugs Production and Production Value (2014-2019) (MT) & (Million US$)
Table Global Steroidal Anti-Inflammatory Drugs Production and Production Value (2014-2019) (MT) & (Million US$)
Table Global Slow Acting Drug Production and Production Value (2014-2019) (MT) & (Million US$)
Table Global Immunological Preparation Production and Production Value (2014-2019) (MT) & (Million US$)
Table Global Antirheumatics Pharmaceutical Production by Type (2014-2019) (MT)
Table Global Antirheumatics Pharmaceutical Production Share by Type (2014-2019)
Figure Global Antirheumatics Pharmaceutical Production Market Share by Type (2014-2019)
Figure Global Antirheumatics Pharmaceutical Production Market Share by Type in 2018
Table Global Antirheumatics Pharmaceutical Production Value by Type (2014-2019) (Million US$)
Table Global Antirheumatics Pharmaceutical Production Value Share by Type (2014-2019)
Figure Global Antirheumatics Pharmaceutical Production Value Market Share by Type (2014-2019)
Figure Global Antirheumatics Pharmaceutical Production Value Market Share by Type in 2018
Table Antirheumatics Pharmaceutical Ex-factory Price by Type 2014-2019 (USD/MT)
Table Global Antirheumatics Pharmaceutical Consumption by Application (2014-2019) (MT)
Table Global Antirheumatics Pharmaceutical Consumption Share by Application (2014-2019)
Figure Global Consumption Antirheumatics Pharmaceutical Market Share by Application (2014-2019)
Table Global Antirheumatics Pharmaceutical Production by Regions 2014-2019 (MT)
Table Global Antirheumatics Pharmaceutical Production Market Share by Regions 2014-2019
Figure Global Antirheumatics Pharmaceutical Production Market Share by Regions 2014-2019
Figure Global Antirheumatics Pharmaceutical Production Market Share by Regions in 2018
Table Global Antirheumatics Pharmaceutical Production Value by Regions 2014-2019 (Million USD)
Table Global Antirheumatics Pharmaceutical Production Value Market Share by Regions 2014-2019
Figure Global Antirheumatics Pharmaceutical Production Value Market Share by Regions 2014-2019
Figure Global Antirheumatics Pharmaceutical Production Value Market Share by Regions in 2018
Table United States Antirheumatics Pharmaceutical Production and Value 2014-2019 (MT) & (Million USD)
Figure United States Antirheumatics Pharmaceutical Production Growth Rate 2014-2019 (MT)
Figure United States Antirheumatics Pharmaceutical Production Value Growth Rate 2014-2019 (Million USD)
Table United States Antirheumatics Pharmaceutical Import & Export (MT)
Table Europe Antirheumatics Pharmaceutical Production and Value 2014-2019 (MT) & (Million USD)
Figure Europe Antirheumatics Pharmaceutical Production Growth Rate 2014-2019 (MT)
Figure Europe Antirheumatics Pharmaceutical Production Value Growth Rate 2014-2019 (Million USD)
Table Europe Antirheumatics Pharmaceutical Import & Export (MT)
Table China Antirheumatics Pharmaceutical Production and Value 2014-2019 (MT) & (Million USD)
Figure China Antirheumatics Pharmaceutical Production Growth Rate 2014-2019 (MT)
Figure China Antirheumatics Pharmaceutical Production Value Growth Rate 2014-2019 (Million USD)
Table China Antirheumatics Pharmaceutical Import & Export (MT)
Table Japan Antirheumatics Pharmaceutical Production and Value 2014-2019 (MT) & (Million USD)
Figure Japan Antirheumatics Pharmaceutical Production Growth Rate 2014-2019 (MT)
Figure Japan Antirheumatics Pharmaceutical Production Value Growth Rate 2014-2019 (Million USD)
Table Japan Antirheumatics Pharmaceutical Import & Export (MT)
Table Global Antirheumatics Pharmaceutical Consumption by Regions 2014-2019 (MT)
Table Global Antirheumatics Pharmaceutical Consumption Market Share by Regions 2014-2019
Figure Global Antirheumatics Pharmaceutical Consumption Market Share by Regions 2014-2019
Figure Global Antirheumatics Pharmaceutical Consumption Market Share by Regions in 2018
Figure North America Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Table North America Antirheumatics Pharmaceutical Consumption by Type (2014-2019) (MT)
Figure North America Antirheumatics Pharmaceutical Consumption Market Share by Type in 2018
Table North America Antirheumatics Pharmaceutical Consumption by Application (2014-2019) (MT)
Figure North America Antirheumatics Pharmaceutical Consumption Market Share by Application in 2018
Table North America Antirheumatics Pharmaceutical Consumption by Countries (2014-2019) (MT)
Figure North America Antirheumatics Pharmaceutical Consumption Market Share by Countries in 2018
Figure United States Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Canada Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Mexico Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Europe Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Table Europe Antirheumatics Pharmaceutical Consumption by Type (2014-2019) (MT)
Figure Europe Antirheumatics Pharmaceutical Consumption Market Share by Type in 2018
Table Europe Antirheumatics Pharmaceutical Consumption by Application (2014-2019) (MT)
Figure Europe Antirheumatics Pharmaceutical Consumption Market Share by Application in 2018
Table Europe Antirheumatics Pharmaceutical Consumption by Countries (2014-2019) (MT)
Figure Europe Antirheumatics Pharmaceutical Consumption Market Share by Countries in 2018
Figure Germany Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure France Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure UK Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Italy Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Russia Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Asia Pacific Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Table Asia Pacific Antirheumatics Pharmaceutical Consumption by Type (2014-2019) (MT)
Figure Asia Pacific Antirheumatics Pharmaceutical Consumption Market Share by Type in 2018
Table Asia Pacific Antirheumatics Pharmaceutical Consumption by Application (2014-2019) (MT)
Figure Asia Pacific Antirheumatics Pharmaceutical Consumption Market Share by Application in 2018
Table Asia Pacific Antirheumatics Pharmaceutical Consumption by Regions (2014-2019) (MT)
Table Asia Pacific Antirheumatics Pharmaceutical Consumption Market Share by Countries (2014-2019)
Figure China Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Japan Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure South Korea Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure India Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Australia Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Indonesia Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Thailand Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Malaysia Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Philippines Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Vietnam Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Central & South America Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Table Central & South America Antirheumatics Pharmaceutical Consumption by Type (2014-2019) (MT)
Figure Central & South America Antirheumatics Pharmaceutical Consumption Market Share by Type in 2018
Table Central & South America Antirheumatics Pharmaceutical Consumption by Application (2014-2019) (MT)
Figure Central & South America Antirheumatics Pharmaceutical Consumption Market Share by Application in 2018
Table Central & South America Antirheumatics Pharmaceutical Consumption by Countries (2014-2019) (MT)
Figure Central & South America Antirheumatics Pharmaceutical Consumption Market Share by Countries
Figure Brazil Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Middle East and Africa Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Table Middle East and Africa Antirheumatics Pharmaceutical Consumption by Type (2014-2019) (MT)
Figure Middle East and Africa Antirheumatics Pharmaceutical Consumption Market Share by Type in 2018
Table Middle East and Africa Antirheumatics Pharmaceutical Consumption by Application (2014-2019) (MT)
Figure Middle East and Africa Antirheumatics Pharmaceutical Consumption Market Share by Application in 2018
Figure Turkey Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure GCC Countries Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure Egypt Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Figure South Africa Antirheumatics Pharmaceutical Consumption Growth Rate (2014-2019) (MT)
Table AbbVie Company Details
Table AbbVie Description and Business Overview
Table AbbVie Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table AbbVie Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table AbbVie Antirheumatics Pharmaceutical Production Market Share in Global Market
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen Description and Business Overview
Table Amgen Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Amgen Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table Amgen Antirheumatics Pharmaceutical Production Market Share in Global Market
Table Amgen Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table Pfizer Antirheumatics Pharmaceutical Production Market Share in Global Market
Table Pfizer Recent Development
Table Roche Holding AG Company Details
Table Roche Holding AG Description and Business Overview
Table Roche Holding AG Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Roche Holding AG Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table Roche Holding AG Antirheumatics Pharmaceutical Production Market Share in Global Market
Table Roche Holding AG Recent Development
Table Novartis International AG Company Details
Table Novartis International AG Description and Business Overview
Table Novartis International AG Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis International AG Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table Novartis International AG Antirheumatics Pharmaceutical Production Market Share in Global Market
Table Novartis International AG Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Johnson & Johnson Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table Johnson & Johnson Antirheumatics Pharmaceutical Production Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Description and Business Overview
Table Bristol-Myers Squibb Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Antirheumatics Pharmaceutical Production Market Share in Global Market
Table Bristol-Myers Squibb Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Merck Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table Merck Antirheumatics Pharmaceutical Production Market Share in Global Market
Table UCB S.A. Company Details
Table UCB S.A. Description and Business Overview
Table UCB S.A. Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table UCB S.A. Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table UCB S.A. Antirheumatics Pharmaceutical Production Market Share in Global Market
Table UCB S.A. Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Description and Business Overview
Table Eli Lilly and Company Antirheumatics Pharmaceutical Production (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Eli Lilly and Company Antirheumatics Pharmaceutical Production Growth Rate (2014-2019)
Table Eli Lilly and Company Antirheumatics Pharmaceutical Production Market Share in Global Market
Table Eli Lilly and Company Recent Development
Table Global Antirheumatics Pharmaceutical Capacity, Production Forecast 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Capacity Forecast 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Production Forecast 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Production Value Forecast 2019-2025 (Million US$)
Table Global Antirheumatics Pharmaceutical Revenue Forecast 2019-2025 (Million US$)
Table Global Antirheumatics Pharmaceutical Production Value Forecast by Regions 2019-2025 (Million US$)
Figure Global Antirheumatics Pharmaceutical Production Value Forecast by Regions 2019-2025 (Million US$)
Figure Global Antirheumatics Pharmaceutical Production Value Market Share Forecast by Regions 2019-2025
Table Global Antirheumatics Pharmaceutical Production Forecast by Regions 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Production Forecast by Regions 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Production Market Share Forecast by Regions 2019-2025
Table United States Antirheumatics Pharmaceutical Production and Value Forecast 2019-2025 (MT) & (Million US$)
Figure United States Antirheumatics Pharmaceutical Production Forecast 2019-2025 (MT)
Figure United States Antirheumatics Pharmaceutical Revenue Forecast 2019-2025 (Million US$)
Table Europe Antirheumatics Pharmaceutical Production and Value Forecast 2019-2025 (MT) & (Million US$)
Figure Europe Antirheumatics Pharmaceutical Production Forecast 2019-2025 (MT)
Figure Europe Antirheumatics Pharmaceutical Revenue Forecast 2019-2025 (Million US$)
Table China Antirheumatics Pharmaceutical Production and Value Forecast 2019-2025 (MT) & (Million US$)
Figure China Antirheumatics Pharmaceutical Production Forecast 2019-2025 (MT)
Figure China Antirheumatics Pharmaceutical Revenue Forecast 2019-2025 (Million US$)
Table Japan Antirheumatics Pharmaceutical Production and Value Forecast 2019-2025 (MT) & (Million US$)
Figure Japan Antirheumatics Pharmaceutical Production Forecast 2019-2025 (MT)
Figure Japan Antirheumatics Pharmaceutical Revenue Forecast 2019-2025 (Million US$)
Table Global Antirheumatics Pharmaceutical Production Forecast by Type 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Production Forecast by Type 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Production Market Share Forecast by Type 2019-2025
Table Global Antirheumatics Pharmaceutical Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Antirheumatics Pharmaceutical Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Antirheumatics Pharmaceutical Production Value Market Share Forecast by Type 2019-2025
Table Global Antirheumatics Pharmaceutical Consumption Forecast by Application 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Consumption Forecast by Application 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Consumption Market Share Forecast by Application 2019-2025
Table Global Antirheumatics Pharmaceutical Consumption Forecast by Regions 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Consumption Forecast by Regions 2019-2025 (MT)
Figure Global Antirheumatics Pharmaceutical Consumption Market Share Forecast by Regions 2019-2025
Table North America Antirheumatics Pharmaceutical Consumption Forecast by Regions 2019-2025 (MT)
Figure United States Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Canada Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Mexico Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Table Europe Antirheumatics Pharmaceutical Consumption Forecast by Regions 2019-2025 (MT)
Figure Germany Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure France Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure UK Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Italy Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Russia Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Table Asia Pacific Antirheumatics Pharmaceutical Consumption Forecast by Regions 2019-2025 (MT)
Figure China Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Japan Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure South Korea Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure India Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Australia Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Indonesia Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Thailand Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Malaysia Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Philippines Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Vietnam Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Table Central & South America Antirheumatics Pharmaceutical Consumption Forecast by Regions 2019-2025 (MT)
Figure Brazil Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Table Middle East and Africa Antirheumatics Pharmaceutical Consumption Forecast by Regions 2019-2025 (MT)
Figure Turkey Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure GCC Countries Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Egypt Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure South Africa Antirheumatics Pharmaceutical Consumption Forecast 2019-2025 (MT)
Figure Antirheumatics Pharmaceutical Value Chain
Table Antirheumatics Pharmaceutical Distributors List
Table Antirheumatics Pharmaceutical Customers List
Table Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
炎症性腸疾患薬の世界市場：インサイト・予測 Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease. The growth in prevalence of inflammatory bowel diseases such as ulcerative …- 抗炎症治療薬の世界市場：インサイト・予測 Anti-inflammatory therapeutics are primarily used to reduce inflammation. These drugs are types of analgesics that are used for reducing pain.The global anti-inflammatory therapeutics market will grow steadily at a CAGR of over 6% by 2021. This market research analysis identifies the increase in the…
- 抗自殺薬の世界市場：インサイト・予測 Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for p…
- 医薬品偽造防止技術の世界市場：市場規模・現状・予測 Counterfeit medicines are manufactured by contaminating or using the wrong compounds with no active ingredient. These are drugs are illegal and pose a significant health risks. Thus, anti-counterfeiting technologies play a pivotal role in the identification of fake medicines. These technologies are …
- 胃腸OTC薬の世界市場：市場規模・現状・予測 Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC…